Skip to main content
. 2006 Dec 14;117(1):99–111. doi: 10.1172/JCI27527

Figure 5. H&E-stained liver tumors from mice treated with WT ARF26–44 peptide.

Figure 5

Hepatic tumors were induced in Foxm1fl/fl mice with DEN/PB treatment, and then they were treated with daily i.p. injections of 5 mg/kg body weight of WT ARF26–44 peptide or mutant ARF37–44 peptide for 4 or 8 weeks (see Figure 2A legend). Arrows indicate red-staining cells undergoing apoptosis, and arrowheads show liver tumor margins. (AF) H&E-stained liver tumor sections from WT ARF26–44 peptide–treated mice revealed that many of the hepatic adenomas and HCC tumor cells stained red and were rounded up, which is indicative of apoptosis. E and F are higher-magnification images of C and D. No red-staining apoptotic cells were found in either the surrounding, normal liver tissue or in liver tumors from dsRNA CKO Mx-Cre Foxm1–/– mice (see Figure 1, E–G). (GL) No red-staining tumor cells were found in H&E-stained liver tumor sections from mice treated with either PBS or mutant ARF37–44 peptide. Magnification, ×200 (AD and GL); ×400 (E and F).

HHS Vulnerability Disclosure